Mike Gorenstein is the CEO and Chairman of Cronos Group, a company focused on building industry leading businesses that transform the perception of cannabis. Cronos is a geographically-diversified and vertically-integrated distributor of medical cannabis products across Canada and Germany through its two wholly-owned Licensed Producers that are regulated under the ACMPR: Peace Naturals (Ontario) and ITZ (British Columbia). Additionally, Cronos Group has entered into a joint venture with Canadian First Nations to form Indigenous Roots Inc., which is focused on producing and supplying medical cannabis to underserved Indigenous communities.
Prior to The Cronos Group, Mr. Gorenstein was a Co-Founder and Partner at Alphabet Ventures, a New York based investment vehicle focused on customized deal structures for both active and passive investment opportunities. Michael’s ability to creatively structure, diligence and negotiate a wide range of transactions drove value for investors. While in this position, Michael supported portfolio companies with strategic, regulatory, legal and operational guidance with a view towards optimizing exit opportunities.
Michael began his career as a corporate attorney at Sullivan & Cromwell in New York, where he advised on over $100B in complex cross-border and domestic M&A, securities and leveraged finance transactions. During his tenure, he provided tactical recommendations and solutions to companies in both the public and the private sectors across multiple industries. Some of his more notable clients include: Diageo, Goldman Sachs, Covidien PLC, Chiquita Brands, Eastman Kodak, HSBC, and AT&T among others.
Michael graduated from the University of Pennsylvania Law School with a JD, the Wharton School at University of Pennsylvania with a certificate in BEPP, and the Kelly School of Business at Indiana University with a BSB in Finance. Additionally, Michael enjoys serving as a mentor for the New York FinTech StartUp BootCamp, which is part of a global family of industry-focused startup accelerators.